人参皂苷Rg3通过CXCL16/CXCR6轴促进CD8+T细胞浸润增加抗肺癌免疫治疗疗效
序号 | 标题 | 类型 | 作者 |
---|---|---|---|
1 | 晚期非小细胞肺癌一线生物靶向治疗的研究进展 | 期刊论文 | 姜战胜;张宇;任秀宝;潘战宇 |
2 | Anlotinib optimizes anti-tumor innate immunity to potentiate the therapeutic effect of PD-1 blockade in lung cancer | 期刊论文 | Yang Yinli;Li Ling;Jiang Zhansheng;Wang Bin;Pan Zhanyu |
3 | Expression of OPN3 in lung adenocarcinoma promotes epithelial-mesenchymal transition and tumor metastasis | 期刊论文 | Xu Chao;Wang Ruixia;Yang Yanfang;Xu Tongyi;Li Yan;Xu Jie;Jiang Zhansheng |
4 | 从西医实体肿瘤疗效评价标准演变思考中医疗效评价体系的建立 | 期刊论文 | 田莹;姜战胜;潘战宇 |
5 | Icotinib alone or with bevacizumab as first-line therapy in Chinese patients with advanced nonsquamous non-small cell lung cancer and activating EGFR mutations: A retrospective study | 期刊论文 | Jiang Zhansheng;Zhang Jing;Sun Haiyan;Wang Cong;Zhang Yu;Li Yanyang;Pan Zhanyu |
6 | 恶性肿瘤患者免疫检查点抑制剂导致肝损伤的临床处理2例 | 期刊论文 | 王作林;杨华夏;陈明;张宇;张新伟;肖建宇;潘战宇;姜战胜 |